(Q53855131)

21 May 2018

title

Induced resistance to the antimicrobial peptide lactoferricin B in Staphylococcus aureus. (English)

1 reference

21 May 2018

main subject

Staphylococcus aureus

1 reference

based on heuristic

inferred from title

antimicrobial peptide

1 reference

1

1 reference

21 May 2018

author name string

Hanne H Haukland

2

1 reference

21 May 2018

Håvard Jenssen

3

1 reference

21 May 2018

Manuela Krämer

4

1 reference

21 May 2018

Kjersti Sandvik

5

1 reference

21 May 2018

Hilde Ulvatne

6

1 reference

21 May 2018

Lars H Vorland

7

1 reference

21 May 2018

language of work or name

English

0 references

publication date

1 June 2005

1 reference

21 May 2018

number of pages

6

1 reference

based on heuristic

inferred from page(s)

published in

FEBS Letters

1 reference

21 May 2018

volume

579

1 reference

21 May 2018

page(s)

3421-3426

1 reference

21 May 2018

issue

16

1 reference

21 May 2018

Cationic peptides: effectors in innate immunity and novel antimicrobials

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Antimicrobial peptides of multicellular organisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Mechanisms of antimicrobial peptide action and resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Intracellular targets of antibacterial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Mode of action of membrane active antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Antimicrobial peptides: potential use in skin infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Antimicrobial peptides: current status and therapeutic potential

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

In vitro resistance of Staphylococcus aureus to thrombin-induced platelet microbicidal protein is associated with alterations in cytoplasmic membrane fluidity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Staphylococcus aureus resistance to human defensins and evasion of neutrophil killing via the novel virulence factor MprF is based on modification of membrane lipids with l-lysine

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Proteases in Escherichia coli and Staphylococcus aureus confer reduced susceptibility to lactoferricin B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Characteristics of Staphylococcus aureus, isolated from airways of cystic fibrosis patients, and their small colony variants

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

The major cold shock gene, cspA, is involved in the susceptibility of Staphylococcus aureus to an antimicrobial peptide of human cathepsin G

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Arming the enemy: the evolution of resistance to self-proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

IB-367, a protegrin peptide with in vitro and in vivo activities against the microflora associated with oral mucositis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Potent Antibacterial Peptides Generated by Pepsin Digestion of Bovine Lactoferrin

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Lactoferrin and cyclic lactoferricin inhibit the entry of human cytomegalovirus into human fibroblasts

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Lactoferrin and lactoferricin inhibit Herpes simplex 1 and 2 infection and exhibit synergy when combined with acyclovir.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Protective effect of lactoferricin against Toxoplasma gondii infection in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Important structural features of 15-residue lactoferricin derivatives and methods for improvement of antimicrobial activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Anti-HSV activity of lactoferricin analogues is only partly related to their affinity for heparan sulfate

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

A new two-component regulatory system involved in adhesion, autolysis, and extracellular proteolytic activity of Staphylococcus aureus

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

Virulence of a hemB mutant displaying the phenotype of a Staphylococcus aureus small colony variant in a murine model of septic arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.FEBSLET.2005.05.017

10.1016/J.FEBSLET.2005.05.017

21 January 2018

Identifiers

DOI

1 reference

21 May 2018

PubMed ID

15946666

1 reference

21 May 2018